SRPT plans FDA filings to convert Amondys 45 and Vyondys 53 to full approvals, leveraging new data despite a missed endpoint in its confirmatory study.
Shares of financial guidance platform NerdWallet (NASDAQ:NRDS) fell 1.9% in the afternoon session after Morgan Stanley ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results